Evidence map›Paper›PMID 39055570›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2024

May Measurement Month 2021: an analysis of blood pressure screening results from China.

Xin Chen, Zhe Hu, Cheng-Bao Lei, Qi-Dong Zheng, Xiao-Long Wang, Thomas Beaney, Carolina Janssen-Telders, Neil R Poulter, Yan Li, Ji-Guang Wang

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. May Measurement Month 2022: an analysis of blood pressure screening results from China.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xin ChenDepartment of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Xiwang Road 999, Shanghai 201801, China.
Zhe HuDepartment of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Xiwang Road 999, Shanghai 201801, China.
Cheng-Bao LeiDepartment of Geriatrics, Sinopharm Tongmei General Hospital, 1 Seventh Wei Road, Xinpingwang Miner Area, Datong 037003, Shanxi Province, China.
Qi-Dong ZhengDepartment of Internal Medicine, The Second People's Hospital of Yuhuan, No. 77, Middle Huanbao Road, Chumen Town, Yuhuan 317605, Zhejiang Province, China.
Xiao-Long WangDepartment of Cardiology, People's Hospital of Hongsibao District, No. 004, Wenhua Street, Hongsibao District, Wuzhong 751900, Ningxia Province, China.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Carolina Janssen-TeldersImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Yan LiDepartment of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Road 197, Shanghai 200025, China.
Ji-Guang WangDepartment of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Xiwang Road 999, Shanghai 201801, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported findings from participants screened during the May Measurement Month 2021 in China, which aimed to raise awareness of raised blood pressure (BP), and to investigate the risk factors of BP. The study participants were adults (≥18 years), ideally in whom BP had not been measured in the previous year. Blood pressure was measured three times consecutively with 1 min intervals in the sitting position, using a validated upper-arm cuff automated BP monitor (Omron HEM-7081IT), and transmitted to a central cloud database via a smartphone app. The measurement was performed in 218 844 participants in 183 sites across 31 China provinces. The mean (standard deviation) age was 47.0 (15.7) years, and 51.8% (

Indexed as

Blood pressureControlHypertensionScreeningTreatment

Identifiers

PMID39055570
PMCPMC11267720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.